Bone Cysts: Clinical Trials

3 trials for Bone Cysts, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3

Follow Bone Cysts: new trials by email Literature Review of Bone Cysts trials Research Report on Bone Cysts

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle - Recurrent Basal Cell Carcinoma
Phase 2TerminatedSol-Gel Technologies, Ltd.502019-12-202026-07-21
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Buparlisib, Sonidegib - Carcinoma, Basal Cell, Recurrent Skin Cancer
Phase 2TerminatedAnne Chang102015-02-012019-01-29
LDE225 for Patients With PTCH1 or SMO Mutated Tumors
LDE225 - PTCH1 or SMO Activated Solid and Hematologic Tumors
Phase 2TerminatedNovartis Pharmaceuticals102014-02-012016-05-02

Narrower conditions

Basal Cell Nevus Syndrome (3)  ·  Carcinoma, Basal Cell (2)  ·  Colonic Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Hematologic Neoplasms (1)  ·  Rombo syndrome (1)  ·  Skin Neoplasms (1)  ·  Syndrome (1)  ·  Xeroderma Pigmentosum (1)

Broader conditions

Abnormalities, Multiple (3)  ·  Bone Diseases (3)  ·  Bone Diseases, Developmental (3)  ·  Carcinoma (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Cysts (3)  ·  Genetic Diseases, Inborn (3)  ·  Jaw Cysts (3)  ·  Jaw Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Basal Cell (3)

Interventions

sonidegib (2)  ·  NVP-BKM120 (1)

Sponsors

Anne Chang (1)  ·  Novartis Pharmaceuticals (1)  ·  Sol-Gel Technologies, Ltd. (1)

Countries

United States (3)

Top investigators

Anne Lynn Chang, MD (1)

Results publications

PMID 29175429